Both in Pharmaceuticals
Amneal Pharmaceuticals vs Ionis Pharmaceuticals
Over the past year AMRX returned +80.5% and IONS returned −45.1%; their daily moves had a correlation of 0.22.
AMRX +80.5% IONS −45.1%Growth of $1, one year, split-adjusted
| Metric | AMRX | IONS |
|---|---|---|
| Price | $20.21 | $40.42 |
| Market cap | $7.04B | $6.72B |
| Today | −1.13% | −1.99% |
| 1 month | −0.7% | −7.1% |
| 6 months | +50.7% | −46.3% |
| Year to date | +60.4% | −48.9% |
| 1 year | +86.8% | −45.6% |
| Revenue growth (YoY) | +9.9% | −40.7% |
| Gross margin | 42.0% | 99.0% |
| Net margin | 7.2% | −42.8% |
| P/E (TTM) | 44.7× | — |
| Price / sales | 2.3× | 7.7× |
| Net cash | -$2.54B | $732.0M |
| Dividend yield | — | — |
| Volatility (60d) | 39.1% | 43.7% |
| Short % of float | 8.2% | 12.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).